Novelix Pharmaceuticals Limited (TRIMURTHI.BO)
- Previous Close
26.61 - Open
26.61 - Bid 26.61 x --
- Ask --
- Day's Range
26.61 - 26.61 - 52 Week Range
24.15 - 26.61 - Volume
550 - Avg. Volume
4,054 - Market Cap (intraday)
264.77M - Beta (5Y Monthly) 0.56
- PE Ratio (TTM)
102.35 - EPS (TTM)
0.26 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date Aug 16, 2012
- 1y Target Est
--
Novelix Pharmaceuticals Limited trades in pharmaceuticals and related products in India. The company is involved in the retail pharmacy business; and distribution of pharmaceutical products. It also trades in shares and securities; and offers marketing services. The company was formerly known as Trimurthi Limited and changed its name to Novelix Pharmaceuticals Limited in October 2024. Novelix Pharmaceuticals Limited was incorporated in 1994 and is based in Hyderabad, India.
www.trimurthidrugs.comRecent News: TRIMURTHI.BO
View MorePerformance Overview: TRIMURTHI.BO
Trailing total returns as of 4/24/2025, which may include dividends or other distributions. Benchmark is S&P BSE SENSEX (^BSESN) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: TRIMURTHI.BO
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: TRIMURTHI.BO
View MoreValuation Measures
Market Cap
264.77M
Enterprise Value
261.01M
Trailing P/E
102.35
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
2.29
Price/Book (mrq)
2.95
Enterprise Value/Revenue
2.44
Enterprise Value/EBITDA
118.82
Financial Highlights
Profitability and Income Statement
Profit Margin
1.85%
Return on Assets (ttm)
--
Return on Equity (ttm)
--
Revenue (ttm)
108.09M
Net Income Avi to Common (ttm)
2M
Diluted EPS (ttm)
0.26
Balance Sheet and Cash Flow
Total Cash (mrq)
1.52M
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
--